NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Tuesday that its second quarter revenues rose 215 percent year over year driven by sales of its rapid pathogen ID molecular diagnostic products.

For the three months ended June 30, the Gaithersburg, Maryland-based firm reported total revenues of $1.2 million compared to $375,146 a year ago. Product sales rose to $1.0 million from $319,171, while lab services revenues rose slightly to $29,674 from $28,195 the year before. Revenues from collaborations rose to $125,000 from $27,780.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.